The Department of Health and Human Services (HHS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) released a final rule titled “Medication Assisted Treatment for Opioid Use Disorders” scheduled to be published in the Federal Register on July 8, 2016. AMCP had submitted comments on the draft rule urging for provisions related to team-based care, education on diversion mitigation strategies, and the expansion of practitioner eligibility to prescribe buprenorphine for opioid abuse disorders.
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to submit comments for the record on the hearing titled “Examining the Proposed Medicare Part B Drug Demonstration” held on June 28, 2016. AMCP submitted detailed comments1 to the Centers for Medicare and Medicaid Services (CMS) in response to the proposed rule titled “Medicare Program; Part B Drug Payment Model (CMS-1670-P)” published in the Federal Register on March 11, 2016.
The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in support of the notice titled “Medicare Part D Reporting Requirements and Supporting Regulations (CMS-10185)” published in the Federal Register on May 6, 2016. Under the notice, Part D sponsors would be responsible for submitting Medication Therapy Management (MTM) program reports as described in Title I, Part 423, Subpart D, § 423.153 for CY2017 by the last Monday of February in 2018.
The Academy of Managed Care Pharmacy (AMCP) supports Senate Bill 2313 –establishing a task force to study and analyze health insurance payer practices regarding the dispensing of specialty drugs directly to a patient or provider. AMCP recommends that the Committee add language including a managed care pharmacist as a member on the task force.
Press Release: The Academy of Managed Care Pharmacy is proud to announce the launch of the Biosimilars Resource Center (BRC), an unbiased, policy-neutral repository of educational resources and information on biosimilars for pharmacists, physicians, nurses and other health care providers.
The Academy of Managed Care Pharmacy (AMCP) supports the passage of Senate Bill 1024. This bill would remove the December 31, 2016 sunset date currently in force which allows health care payment or benefit provider’s access to the state electronic system for monitoring schedules 2-5 controlled substances.
The undersigned pharmacy organizations would like to thank the Centers for Medicare and Medicaid Services (“CMS”) for the opportunity to comment on the Proposed Rule for the Medicare Program; Merit-Based Incentive Payment System and Alternative Payment Model Incentive under the Physician Fee Schedule (“PFS”), and Criteria for Physician-Focused Payment Models (the “Proposed Rule”).
Press Release: The Academy of Managed Care Pharmacy (AMCP) today released a set of recommendations that would allow biopharmaceutical companies to more easily share health care economic information (HCEI) with entities that make formulary and coverage decisions.
Press Release: The Academy of Managed Care Pharmacy (AMCP) Foundation is delighted to announce that six student pharmacists from across the country will participate in summer internship programs offered by the AMCP Foundation in partnership with Allergan, Inc. and Pfizer, Inc.